In-hospital mortality after point-of-care ultrasound in children with asthma: A cross-sectional survey
Published
May 19, 2024
Paper ID
PAP-000183
Status
Published
DOI
10.65712/tmj.test000441
Advance Services
Abstract
Background: in-hospital mortality remains a leading cause of avoidable harm among children with asthma. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Serious adverse events were rare and similar between groups. 473 participants were included (median age 41 years). Conclusion: These findings suggest that point-of-care ultrasound is associated with better in-hospital mortality in children with asthma.
Introduction
Earlier studies of point-of-care ultrasound were small or single-centre. Practice around point-of-care ultrasound varies widely between centres.
Practice around point-of-care ultrasound varies widely between centres. Guidelines make only a weak recommendation on point-of-care ultrasound.
Practice around point-of-care ultrasound varies widely between centres. Guidelines make only a weak recommendation on point-of-care ultrasound. The cost of in-hospital mortality to health systems is substantial.
Guidelines make only a weak recommendation on point-of-care ultrasound.
Discussion
Residual confounding cannot be excluded. These findings suggest that point-of-care ultrasound is associated with better in-hospital mortality in children with asthma. Strengths include the sample size and blinded outcome assessment.
Residual confounding cannot be excluded.
Implementation will depend on staffing, cost and local protocols.
Conclusions
Point-of-care ultrasound may be offered for children with asthma to improve in-hospital mortality.
References
1. Patel R, Lindqvist D, et al. Point-of-care ultrasound and 30-day readmission. Lancet. 2025;102(9):203-1315.
2. Andersen M, Nakamura V, et al. Early mobilisation and medication adherence. Lancet. 2017;323(5):95-1539.
3. Silva Q, Yilmaz K, et al. Prone positioning and medication adherence. BMJ. 2021;238(10):259-1054.
4. Okafor D, Kaur R, et al. A sepsis alert system and time to diagnosis. Pediatrics. 2011;227(1):788-1664.
5. Rossi G, Zhang Y, et al. Nurse-led discharge planning and medication adherence. Lancet. 2015;123(4):759-1170.
6. Tanaka R, Silva N, et al. SGLT2 inhibitors and in-hospital mortality. N Engl J Med. 2017;173(1):574-1311.
7. Silva S, Lindqvist N, et al. High-flow nasal oxygen and 30-day readmission. Ann Intern Med. 2016;239(1):553-987.
8. Ibrahim F, Andersen C, et al. Low-dose aspirin and post-operative delirium. Pediatrics. 2009;343(10):25-1174.
Appendices
Supplementary tables are available on request.
Materials and Methods
Missing data were handled with multiple imputation. We conducted a cross-sectional survey across 11 centres between 2014 and 2022. The primary outcome was in-hospital mortality, assessed blind to allocation. We conducted a cross-sectional survey across 13 centres between 2017 and 2024.
We conducted a cross-sectional survey across 7 centres between 2019 and 2025. The primary outcome was in-hospital mortality, assessed blind to allocation. Missing data were handled with multiple imputation. We conducted a cross-sectional survey across 2 centres between 2014 and 2023.
Results
Serious adverse events were rare and similar between groups. in-hospital mortality occurred in 9% of the intervention group versus 32% of controls.
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Age < 65 | 486 | 24 | 12.8 | 0.71 | 0.51–1.14 |
| Control | 722 | 84 | 22.4 | 0.89 | 0.22–1.36 |
| Centre A | 809 | 64 | 30.2 | 0.85 | 0.52–1.7 |
| Age < 65 | 536 | 95 | 35.7 | 0.82 | 0.48–1.36 |
Values are n (%) unless stated otherwise.

Shown for children with asthma; error bars are 95% confidence intervals.
in-hospital mortality occurred in 22% of the intervention group versus 31% of controls. Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.91 (95% CI 0.27 to 0.79). in-hospital mortality occurred in 12% of the intervention group versus 34% of controls.